Teplitsky Liane Rae has taken a new insider position at Pulse Biosciences, where she is identified as chief operating officer. For investors, the update connects a named executive with the company’s insider-position record and identifies Pulse Biosciences under ticker PLSE, without providing a position size or transaction value.
Key Highlights
- Teplitsky Liane Rae is identified as chief operating officer of PULSE BIOSCIENCES, INC.
- The official regulatory record was submitted to the SEC.
- Pulse Biosciences is identified under ticker PLSE.
The disclosure identifies PULSE BIOSCIENCES, INC (NASDAQ: PLSE). As the organisation associated with the position and names Teplitsky as its chief operating officer.
Executive Position Recorded at Pulse Biosciences
Teplitsky Liane Rae is the individual identified in the official regulatory disclosure. The record was submitted to the U.S. Securities and Exchange Commission. Pulse Biosciences is identified by the ticker PLSE. The disclosure is characterised as a new insider position involving Teplitsky Liane Rae. Teplitsky Liane Rae and PULSE BIOSCIENCES, INC. are the named parties associated with the regulatory record. It also identifies the organisation’s legal name and its ticker, PLSE, within the same record.
FAQs
Q: Who is Teplitsky Liane Rae?
A: Teplitsky Liane Rae is identified as the chief operating officer of PULSE BIOSCIENCES, INC. The regulatory disclosure concerns her new insider position with Pulse Biosciences.
Q: What is the connection between Teplitsky Liane Rae and PLSE?
A: PLSE is the ticker identified for Pulse Biosciences. Teplitsky Liane Rae is named as the company’s chief operating officer in the regulatory disclosure.
Q: What does the Pulse Biosciences insider disclosure concern?
A: The disclosure concerns a new insider position associated with Teplitsky Liane Rae. It identifies her executive role at PULSE BIOSCIENCES, INC. And the company’s PLSE ticker.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.